ALESSANDRO SCARANO

Dr. ALESSANDRO SCARANO


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Materials
Verified
Journal Article
Open access
PDF file
ASALESSANDRO SCARANO
ALESSANDRO SCARANO
RLRoberto Luongo
Roberto Luongo
IFIlaria De Filippis
Ilaria De Filippis
Antonio ScaranoAntonio Scarano
Antonio Scarano
Erda QorriErda Qorri
Erda Qorri
CBCalogero Bugea
Calogero Bugea
Implant–prosthetic rehabilitation of the posterior edentulous maxilla is challenging due to inadequate bone volume resulting from alveolar ridge resorption and maxillary sinus pneumatization. This study explores the use of hyaluronic acid (HA) as a biomaterial in maxillary sinus elevation, particularly in combination with a fluid dynamic approach, as an alternative to traditional lateral approaches and granular biomaterials. Methods: A prospective study was conducted on 58 patients with posterior maxillary edentulism. Preoperative CBCT scans assessed residual bone height and sinus width. A minimally invasive surgical protocol utilizing a device for fluid-dynamic membrane elevation and injection of 2% cross-linked hyaluronic acid was employed, followed by simultaneous implant placement. Postoperative follow-up included a CBCT scan at 12 months to evaluate new bone height, measured mesially and distally. Implant stability was assessed using resonance frequency analysis at second-stage surgery. Results: A significant increase in bone height was observed at 12 months post-surgery, with an average bone gain of 7.5 mm. All 58 implants achieved primary stability, and no implant failures or signs of peri-implantitis were noted during the follow-up period. Higher bone gain was observed in wider sinuses. Conclusions: The fluid-dynamic transcrestal sinus floor elevation technique combined with hyaluronic acid appears to be a minimally invasive and effective method for achieving significant bone regeneration in the posterior maxilla, facilitating implant–prosthetic rehabilitation with potentially low risks and morbidity. Further large-scale studies are warranted to validate these findings across diverse clinical scenarios.

10 July 2026 in Prosthesis
Verified
Journal Article
Open access
PDF file
Gaetano MarenziGaetano Marenzi
Gaetano Marenzi
Gennaro RuggieroGennaro Ruggiero
Gennaro Ruggiero
Fabrizio BergaminelliFabrizio Bergaminelli
Fabrizio Bergaminelli
AMAlessandra Miniello
Alessandra Miniello
ASALESSANDRO SCARANO
ALESSANDRO SCARANO
Roberto SorrentinoRoberto Sorrentino
Roberto Sorrentino
Objectives: The aim of the study was to compare CBCT (Cone Beam Computed Tomography)-derived radiographic hard tissue gain after hydraulic transcrestal sinus floor elevation performed with versus without cross-linked hyaluronic acid (HA) and to assess associated clinical, radiographic, and patient-reported outcomes. Materials and Methods: This single-center, prospective clinical study enrolled 58 patients with 2–6 mm residual bone height in the posterior maxilla, assigned in a non-randomized parallel-group design to HA (n = 29) or No Graft (n = 29). The primary endpoint was CBCT-based 3D CBCT-derived radiographic hard-tissue volume gain at 12 months; secondary endpoints included vertical bone gain, marginal bone loss (MBL) at 12 and 24 months, implant stability quotient (ISQ), implant survival/success, complications, and patient-reported outcomes (VAS pain, OHIP-14). Analyses used ANCOVA and appropriate comparative statistics. Results: At 12 months, mean CBCT-derived radiographic hard-tissue volume gain was higher with HA (1210 +/− 610 mm3) than with No Graft (858 +/− 605 mm3; adjusted difference +352 mm3, 95% CI: 140–564; p = 0.002). ISQ at 12 months was greater with HA (p = 0.028), while MBL at 12/24 months did not differ significantly. Twenty-four-month implant survival was 98.1% (HA) vs. 94.3% (No Graft; p = 0.041). Complication rates were low and comparable; VAS pain at 72 h was modestly lower with HA. Conclusions: In this non-randomized prospective clinical study, cross-linked hyaluronic acid was associated with greater CBCT-derived radiographic hard-tissue volume gain and vertical radiographic gain after hydraulic transcrestal sinus floor elevation compared with clot stabilization alone. Clinical outcomes were favorable in both groups during the 24-month observation period. These findings support the interpretation of cross-linked hyaluronic acid as a potential space-maintaining adjunct in posterior maxillary sites with limited residual bone height; however, because no histological or histomorphometric assessment was performed, they should not be interpreted as proof of vital mature bone regeneration or superior bone quality.